Aprea Therapeutics, Inc. (APRE) vs Moleculin Biotech, Inc. (MBRX)
- Aprea Therapeutics, Inc. APRE 0.58 −6.45%
- Moleculin Biotech, Inc. MBRX 0.28 −24.32%
Aprea Therapeutics, Inc. and Moleculin Biotech, Inc. are both Biotechnology companies. Aprea Therapeutics, Inc. and Moleculin Biotech, Inc. are of similar size ($7.8M and $7.6M). Aprea Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.0×. Across the 11 metrics below, Aprea Therapeutics, Inc. leads on 6 and Moleculin Biotech, Inc. on 5.
Valuation
Profitability
| Metric | APRE | MBRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (47.44%) | (1,471.05%) | (56.36%) |
| Return on assets | (41.30%) | (152.41%) | (48.04%) |
| Return on invested capital | 0.00% | (417.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack